Blacklist or Black PR? Counter-Marketing of Intestinal Adsorbents in the Media

Blacklist or Black PR? Counter-Marketing of Intestinal Adsorbents in the Media

Authors

Keywords:

Counter-marketing, marketing, Enterosgel, Polymethylsiloxane polyhydrate, activated carbon, Polysorb, Colloidal silicon dioxide, mass media, Internet

Abstract

The managerial decision making process requires understanding of counter-marketing techniques in the media for objective interpretation of the facts amid information overload. The article contains the principles for routine tracking of counter-marketing data in the media in the field of pharmacy, illustrated by examples of Enterosgel, Polysorb and activated carbon. Counter-marketing often involves a straw man fallacy. The negative messages may cover the country in which the product is manufactured, the product group and the manufacturer. Then these messages shift to attack the product, and these tactics can be used for lobbying decisions. The authors discuss the methods and results of counter-marketing in the media involving manufacturers of medicinal products from group A07B according to the ATC classification, or intestinal adsorbents. The variety of intestinal adsorbents in Russia and the CIS is tremendous, due to R&D carried out in the USSR. The choice of A07B group provides the opportunity to view counter-marketing not only as a tool of competitors, but also as an instrument of international large-scale influence, way beyond the usual brand wars. The study methods include the analysis of routine pharmacovigilance, requests from regulatory authorities, messages from contractors and users and media publications from 2012 to 2020. Counter-marketing is widely used globally, as attested by the instances of discrediting intestinal adsorbents in the media. However, wise use of counter-marketing has the power to neutralize negative messages by turning them in favor of the manufacturer.

Author Biographies

Alexander V. Khovanov, TNC SILMA

PhD, Associate Professor, TNC SILMA, Moscow, Russian Federation. 

khovanoff_alex@mail.ru

Olga A. Minchina, TNC SILMA

Marketing Manager, TNC SILMA, Moscow, Russian Federation.

olga-minchina@mail.ru

References

Бехтерева М.К., Комарова А.М., Усков А.Н., Раздьяконова И.В., Алексеева Л.А., Бессонова Т.В. Оценка эффективности желатина танната при острых инфекционных диареях у детей // Детские инфекции. 2017. Т. 16. № 4. С. 58–63. DOI: https://doi.org/10.22627/2072-8107-2017-16-4-58-63.

Галкина Г.А., Грибкова Е.И., Курашов М.М., Раснер Е.М. Анализ энтеросорбентов, представленных в розничном звене фармацевтического рынка // Фармация. 2017. Т. 66. № 6. С. 38–41.

Никонов В.А. Современный мир и его истоки. М.: Издательство Московского университета, 2015.

Павлов А.И., Хованов А.В., Хаваншанов А.К., Фадина Ж.В., Шамес А.Б. Место современной энтеросорбции в лечении и профилактике алкогольной болезни печени (обзор литературы) // Эффективная фармакотерапия. 2019. Т. 15. № 18. С. 36–41. DOI: 10.33978/2307-3586-2019-15-18-36-41.

Панфилова В.Н., Таранушенко Т.Е. Применение энтеросорбентов в клинической практике // Педиатрическая фармакология. 2012. Т. 9. № 6. С. 34–39. DOI: https://doi.org/10.15690/pf.v9i6.516.

Уваров Д.А. Анализ структуры государственных закупок лекарственных средств с недоказанной эффективностью // Государственное управление. Электронный вестник. 2020. № 80. С. 84–104. DOI: 10.24411/2070-1381-2019-10065.

Усенко Д.В., Горелова Е.А., Рудык А.В. Применение энтеросорбентов в лечении кишечных инфекций у детей с сопутствующим атопическим дерматитом // Фарматека. 2015. № 10. С. 31–35.

Grøndahl V.A., Kirchhoff J.W., Andersen K.L., Sørby L.Aa., Andreassen H.M., Skaug E.-A., Roos A.K., Tvete L.S., Helgesen A.K. Health Care Quality from the Patients’ Perspective: A Comparative Study Between an Old and a New, High-Tech Hospital // Journal of Multidisciplinary Healthcare. 2018. Is. 11. P. 591–600. DOI: 10.2147/JMDH.S176630.

Howell C.A., Markaryan E., Allgar V., Kemppinen A., Khovanov A., Pandya P., Arasaradnamet R. Enterosgel for the Treatment of Adults with Acute Diarrhoea in a Primary Care Setting: A Randomised Controlled Trial // BMJ Open Gastroenterology. 2019a. Vol. 6. Is. 1. DOI: 10.1136/bmjgast-2019-000287.

Howell C.A., Mikhalovsky S., Markaryan E.N., Khovanov A.V. Investigation of the Adsorption Capacity of the Enterosorbent Enterosgel for a Range of Bacterial Toxins, Bile Acids and Pharmaceutical Drugs // Scientific Reports. 2019b. Vol. 9. Is. 1.

DOI: https://doi.org/10.1038/s41598-019-42176-z.

Kabakova T.I., Goryachev A.B., Prokopenko V.V., Khovanov A.V., Terekhova L.V., Kondratov S.Yu., Popova E.A. Marketing Research of the Regional Pharmaceutical Market for Enterosorbent Medicinal Drugs // Systematic Reviews in Pharmacy. 2020. Vol. 11. Is. 7. P. 470–474. DOI: 10.31838/srp.2020.7.68.

Kemppinen A., Howell C., Allgar V., Dodd M., Gregson J., Knowles Ch., McLaughlin J., Pandya P., Whorwell P., Markaryan E., Yiannakou Y. Randomised, Double-Blind, Placebo Controlled Multi-Centre Study to Assess the Efficacy, Tolerability and Safety of Enterosgel® in the Treatment of Irritable Bowel Syndrome with Diarrhoea (IBS-D) in Adults // Trials. 2020.

Is. 21. DOI: https://doi.org/10.1186/s13063-020-4069-x.

Downloads

Published

2021-10-30

How to Cite

Blacklist or Black PR? Counter-Marketing of Intestinal Adsorbents in the Media . (2021). Public Administration. E-Journal (Russia), 84, 62-84. https://spajournal.ru/index.php/spa/article/view/214

Issue

Section

Scientific articles

Categories

How to Cite

Blacklist or Black PR? Counter-Marketing of Intestinal Adsorbents in the Media . (2021). Public Administration. E-Journal (Russia), 84, 62-84. https://spajournal.ru/index.php/spa/article/view/214

Similar Articles

1-10 of 47

You may also start an advanced similarity search for this article.

Loading...